Spring 2023 Short Bits from Doc Gumshoe
27 Comments Read MoreArticles
Women, Statins and Curry
Responses to Questions and Comments: August 2021
I was hoping to keep COVID-19 out of this piece, but new things keep flooding in, and I can’t totally ignore them. However, I’ll save them to the end of the story. They are both “good news,” more or less, and I like to leave you with a bit of cheer, when possible. Sleep and […]
37 Comments Read MoreMore About COVID-19: Where Are We Now and Where Are We Headed?
Thinkolating on Ray Blanco’s tease: “Fighting The Coronavirus: 3 Companies That Could Save Lives and Make You a Fortune”
Doc Gumshoe – Short & Easy Bits
Doc Gumshoe's updates on the Apple Watch, Physician Shortages, Ebola, Prostate Screenings and more
13 Comments Read MoreMarch 2018 Catch Up: What’s Been Happening in the Pharm World?
Bulletins from the Cardiac Front
Trump’s “Mystery Holding” teased by Oxford Club
"The Shocking Surprise I Found in Trump's Personal Stock Portfolio" -- What's the "secretive, under-the rader company with a stranglehold on a super lucrative niche" hinted at by Chris Matthai?
13 Comments Read MoreMarc Lichtenfeld “Bets His Paycheck” — “GMS” Stock revealed
“Friday, May 6 at 9:30AM, You Could Have the Chance to DOUBLE Your Money when This Tiny Tech Company Goes Public…”
Cancer Care: Current Directions
The 2015 Stock Gumshoe Biotechnology Awards Show!
Doc Gumshoe’s News: Some Good, Some Not So Good
[ed note: Michael Jorrin, who we like to call “Doc Gumshoe”, is a longtime medical writer (not a doctor) who writes non-investment articles about medicine and health topics for us once or twice a month. As with all of our guest contributors and columnists, he chooses his own topics and his words are his alone] […]
23 Comments Read MoreA Non-Statin Pill That Really Lowers Cholesterol, Blood Pressure and Inflammation without Side Effects Would be a Good Investment, Right?
Will PCSK9 Inhibitors Be the Next Blockbusters in Cardiovascular Disease?
We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.
More Info
Comments
From 12apr2022, CTX also known as CRISPR technology:#1) Vertex Pharmaceutical (VRTX) Buy-up-to $220...
KEYS 1 year stock price change: + 81.78%; BMRN: +6.72%; REGN: +9.22%; VRTX: -0.22%...
4 stocks recommended in special reports from March 2021: KEYS, BMRN, REGN, and VRTX. I am a subscriber to the Near Futu...
JB's has only four biotech recommendations on his $49/yr service: they are ILMN and REGN, BMRN, and VRTX. The only one t...
More to the point of the stocks - glad I didn’t give them any money since I’m already invested in three of the four ...
Ray has pushed INO and GILD multiple times over the prior month but no mention of REGN in this publication....
Top 3 Coronavirus stocks Regeneron Pharma (REGN) BioNtec (BNTX) MaAerns Inc. (MRNA) Thank:-:You FRANK8MORRISS frankeight...
Trump drug pricing speech tomorrow 2PM will focus on Medicare Part B drugs --> $IBB $XBI $REGN TY https://twitter.com/A...
$OPTH longBTW, the approval of a "me-too" drug for wet AMD, Eylea, gave us Regeneron, $REGN.Just sayin.......eyed...
$OPHT NP with itchy trigger fingerSo little mad money, but so many, many binary situations in biotech to trip over!...
CRISPR/Cas9 company Intellia getting set for 140 million IPO with a 75 million partnership intact with Regeneron (REGN) ...
Morgan Stanley has 44 stocks on takeover target radar, including 3 biopharma - Celgene (CELG), Regeneron (REGN) and Ale...